📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. (2016)

First Author: Verhoef TI

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/tpj.2016.41

PubMed Identifier: 27272045

Publication URI: http://europepmc.org/abstract/MED/27272045

Type: Journal Article/Review

Volume: 16

Parent Publication: The pharmacogenomics journal

Issue: 5

ISSN: 1470-269X